Journal of the American Academy of Dermatology
Volume 59, Issue 2 , Pages 209-217, August 2008

National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents

  • Sean D. Doherty, MD

      Affiliations

    • Department of Dermatology, Baylor College of Medicine, Houston, Texas
    • ,
  • Abby Van Voorhees, MD

      Affiliations

    • Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Mark G. Lebwohl, MD

      Affiliations

    • Department of Dermatology, Mount Sinai School of Medicine, New York, New York
    • ,
  • Neil J. Korman, MD, PhD

      Affiliations

    • Department of Dermatology and the Murdough Family Center for Psoriasis, Case Western Reserve University/University Hospital of Cleveland, Cleveland, Ohio
    • ,
  • Melodie S. Young, MSN, RN

      Affiliations

    • private practice, Dallas, Texas
    • ,
  • Sylvia Hsu, MD

      Affiliations

    • Department of Dermatology, Baylor College of Medicine, Houston, Texas
    • Corresponding Author InformationReprint requests: Sylvia Hsu, MD, Professor, Department of Dermatology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030.

Accepted 18 March 2008. published online 16 May 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding sources: None.

 Disclosure: Dr Van Voorhees has been a consultant and speaker for Abbott, Amgen, Centocor, and Genentech. Dr. Lebwohl has been a consultant for Abbott, Amgen, Astellas, Centocor, Genentech, and Wyeth; he has also been a speaker for Abbott, Amgen, Astellas, Centocor, and Genentech. Dr Korman has been a consultant for Abbott, Astellas, Centocor, and Genentech; he has also been a speaker for Abbott, Amgen, Astellas, Centocor, and Genentech. Ms Young has been a consultant and speaker for Abbott, Amgen, Astellas, Centocor, and Genentech. Dr Hsu has been a consultant for Abbott, Amgen, Biogen Idec, Centocor, and Genentech; she has also been a clinical investigator for Amgen and Centocor. Dr Doherty has no conflicts of interest to declare.

PII: S0190-9622(08)00393-9

doi:10.1016/j.jaad.2008.03.023

Journal of the American Academy of Dermatology
Volume 59, Issue 2 , Pages 209-217, August 2008

Article Tools

* Image Usage & Resolution